Clinical Guidelines for Drug-induced Peptic Ulcer, 2020 Revised Edition

Korean College of Helicobacter and Upper Gastrointestinal Research

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

The Korean guidelines for nonsteroidal anti-inflammatory drug (NSAID)-induced peptic ulcers were previously developed under co-work with the Korean College of Helicobacter and Upper Gastrointestinal Research and Korean Society of Gastroenterology at 2009. On the other hand, the previous guidelines were based mainly on a literature review and expert opinions. Therefore, the guidelines need to be revised. In this study, a guideline development committee for drug-induced peptic ulcers was organized under the Korean College of Helicobacter and Upper Gastrointestinal Research in 2017. Nine statements were developed, including four for NSAID, three for aspirin and other antiplatelet agents, and two for anticoagulants through de novo processes based on evidence-based medicine, such as a literature search, meta-analysis, and the consensus was established using the modified Delphi method. The primary target of this guideline was adult patients taking long-term NSAIDs, aspirin, or other antiplatelet agent and anticoagulants. The revised guidelines reflect the consensus of expert opinions and are intended to assist relevant clinicians in the management and prevention of drug-induced peptic ulcers and associated conditions.

Original languageEnglish
Pages (from-to)108-133
Number of pages26
JournalThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
Volume76
Issue number3
DOIs
StatePublished - 25 Sep 2020

Keywords

  • Anti-inflammatory agents
  • Anticoagulants
  • Antiplatelet agent
  • Guideline
  • non-steroidal
  • Peptic ulcer

Fingerprint

Dive into the research topics of 'Clinical Guidelines for Drug-induced Peptic Ulcer, 2020 Revised Edition'. Together they form a unique fingerprint.

Cite this